Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusioncycle: An open-label pharmacokinetic cohort study

BMC Musculoskeletal Disorders

Volumn 12, Issue , 2011, Pages

  Van Den Bemt, Bart Jf ^a   Den Broeder, Alfons A ^a   Wolbink, Gj ^b   Hekster, Yechiel A ^c   Van Riel, Piet Lcm ^c   Benraad, Bart ^a   Van Den Hoogen, Frank Hj ^a  

^a Sint Maartenskliniek ^*  (Netherlands)

^b SANQUIN RESEARCH   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; INFLIXIMAB; METHOTREXATE; PREDNISONE; RHEUMATOID FACTOR; ANTIIDIOTYPIC ANTIBODY; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG BLOOD LEVEL; FEMALE; HUMAN; MALE; RHEUMATOID ARTHRITIS; BIOSYNTHESIS; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; DRUG RESISTANCE; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PREDICTIVE VALUE; PROSPECTIVE STUDY;

AGED; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COHORT STUDIES; DRUG RESISTANCE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 78651334129     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-12-12     Document Type: Article

References (17)

1. Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset Study Group. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. EW St Clair DM van der Heijde JS Smolen, et al. Arthritis Rheum 2004 50 3432 43 10.1002/art.20568 15529377
2. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. FC Breedveld MH Weisman AF Kavanaugh SB Cohen K Pavelka R van Vollenhoven J Sharp JL Perez GT Spe (Pubitemid 43122183)
3. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. L Klareskog D van der Heijde JP de Jager, et al. Lancet 2004 363 675 81 10.1016/S0140-6736(04)15640-7 15001324 (Pubitemid 38296553)
4. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. PE Lipsky DM van der Heijde EW St Clair, et al. N Engl J Med 2000 343 1594 602 10.1056/NEJM200011303432202 11096166
5. When patients with rheumatoid arthritis fail tumour necrosis factor inhibitors: what is the next step? JS Smolen ME Weinblatt, Ann Rheum Dis 2008 67 11 1497 8 10.1136/ard.2008.098111 18854512
6. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. RB Landewe M Boers AC Verhoeven, et al. Arthritis Rheum 2002 46 347 56 10.1002/art.10083 11840436 (Pubitemid 34136571)
7. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies. T Bongartz AJ Sutton MJ Sweeting I Buchan EL Matteson V Montori, JAMA 2006 295 2275 85 10.1001/jama.295.19.2275 16705109
8. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. WG Dixon K Watson M Lunt KL Hyrich AJ Silman DP Symmons, Arthritis Rheum 2006 54 2368 76 10.1002/art.21978 16868999 (Pubitemid 44204996)
9. Utrecht Rheumatoid Arthritis Cohort study group. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). SM Verstappen JW Jacobs MJ van der Veen AH Heurkens Y Schenk EJ ter Borg, et al. Ann Rheum Dis 2007 66 11 1443 9 10.1136/ard.2007.071092 17519278 (Pubitemid 350032650)
10. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. C Grigor H Capell A Stirling AD McMahon P Lock R Vallance, et al. Lancet 2004 364 9430 263 9 10.1016/S0140-6736(04)16676-2 15262104 (Pubitemid 38942816)
11. Dose escalation of infliximab in clinical practice: improvements seen may be explained by a regression-like effect. RF van Vollenhoven S Brannemark L Klareskog, Ann Rheum Dis 2004 63 4 426 30 10.1136/ard.2003.010967 15020338 (Pubitemid 38453310)
12. Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab. K Bendtzen P Geborek M Svenson L Larsson MC Kapetanovic T Saxne, Arthritis Rheum 2006 54 3782 9 10.1002/art.22214 17133559 (Pubitemid 44955878)
13. Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis. GJ Wolbink M Vis W Lems AE Voskuyl E de Groot MT Nurmohamed, et al. Arthritis Rheum 2006 54 711 15 10.1002/art.21671 16508927
14. Immunogenicity of Anti-TNF-alpha agents in autoimmune diseases. N Emi Aikawa JF de Carvalho C Artur Almeida Silva E Bonf Clin Rev Allergy Immunol 2010 38 2-3 82 9 10.1007/s12016-009-8140-3 19565360
15. Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis. GJ Wolbink AE Voskuyl WF Lems E de Groot MT Nurmohamed PP Tak, et al. Ann Rheum Dis 2005 64 704 7 10.1136/ard.2004.030452 15485995 (Pubitemid 40559296)
16. Rapid alleviation of signs and symptoms of rheumatoid arthritis with intravenous or subcutaneous administration of adalimumab in combination with methotrexate. R Rau S Simianer PL van Riel LB van de Putte K Krüger M Schattenkirchner, et al. Scand J Rheumatol 2004 33 3 145 53 10.1080/ 03009740410005467 15228184 (Pubitemid 38748100)
17. The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis. PM Welsing RB Landewé PL van Riel M Boers AM van Gestel S van der Linden, et al. Arthritis Rheum 2004l 50 7 2082 93 10.1002/art.20350 (Pubitemid 38924385)